卫信康：吸入用乙酰半胱氨酸溶液获药品注册证书

Core Viewpoint - Weixingkang (603676) announced that its wholly-owned subsidiary Yangpu Jingtai has received the drug registration certificate for inhaled acetylcysteine solution from the National Medical Products Administration [1] Company Summary - The inhaled acetylcysteine solution is a mucolytic agent used for treating respiratory diseases characterized by excessive thick mucus secretion [1]